Search results
Results from the WOW.Com Content Network
Jatropha curcas is a species of flowering plant in the spurge family, Euphorbiaceae, that is native to the American tropics, most likely Mexico and Central America. [2] It is originally native to the tropical areas of the Americas from Mexico to Argentina, and has been spread throughout the world in tropical and subtropical regions around the world, becoming naturalized or invasive in many ...
Jatropha is a genus of flowering plants in the spurge family, Euphorbiaceae. The name is derived from the Greek words ἰατρός ( iatros ), meaning "physician", and τροφή ( trophe ), meaning "nutrition", hence the common name physic nut .
Jatropha rivae is a deciduous shrub, growing up to 2.5 metres (8 ft) tall, with purple-brown young twigs. [1] [2] The leaves are 5–35 mm long, 5–15 mm wide and oblanceolate to obovate in shape, with a wedge-shaped (cuneate) base and 0–2 mm long petiole. The leaf margin is entire to dentate or sinuately lobed, and the apex is rounded to ...
Jatropha gossypiifolia, commonly known as bellyache bush, black physicnut or cotton-leaf physicnut, is a species of flowering plant in the spurge family, Euphorbiaceae. [2] The species is native to Mexico, South America, and the Caribbean islands , but is currently spread throughout the tropics. [ 3 ]
Jatropha elliptica is a species of flowering plant, a shrub in the family Euphorbiaceae. [2]The species is native to Bolivia, Brazil, and Paraguay. [1]It is used in folk medicine to treat itches, snake bites, syphilis, ulcer, urinary discharge, neoplasia, and abdominal issues. [3]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Jatropha podagrica is a species of flowering, caudiciform succulent plant in the spurge family,Euphorbiaceae, aligning it closely with related genera such as Croton, Euphorbia and Ricinus (castor bean), among others.
Despite the clinic’s failure rate, she has not considered making the medication more accessible. “I don’t know how to answer that question,” she said. “We are an abstinence-based program by nature.” The state’s treatment providers have little idea how their patients fare once they walk out the door.